Jazz Pharmaceuticals plc 4

Insider Ted W. Love had a total of 743 Jazz Pharmaceuticals plc ordinary shares disposed of on August 31, 2026, primarily to satisfy tax obligations from RSU vesting.

On August 31, 2026, Ted W. Love, an insider of Jazz Pharmaceuticals plc, disposed of small amounts of ordinary shares in two separate transactions reported with transaction code “F,” indicating shares withheld or sold to cover tax obligations related to the vesting of previously granted restricted stock units. The first transaction involved 6 shares at an average price of approximately $244.06 per share and the second involved 737 shares at approximately $241.39 per share, both treated as dispositions held in direct ownership. Following these tax-related sales, Love’s direct holdings decreased to 3,126 ordinary shares after the first transaction and then to 2,389 ordinary shares after the second transaction. These transactions appear to be routine tax-withholding events associated with equity compensation rather than discretionary open-market selling.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001188919-26-000015

Alert Tier

4